Scarica l'app Stockscreener
105.25
4.45%
4.48
Dopo l'orario di chiusura:
106.50
1.25
+1.19%
Precedente Chiudi:
$100.77
Aprire:
$102.895
Volume 24 ore:
1.24M
Relative Volume:
1.13
Capitalizzazione di mercato:
$4.87B
Reddito:
-
Utile/perdita netta:
$-63.78M
Rapporto P/E:
-39.27
EPS:
-2.68
Flusso di cassa netto:
$-53.91M
1 W Prestazione:
-0.36%
1M Prestazione:
+23.61%
6M Prestazione:
+737.98%
1 anno Prestazione:
+734.66%
Intervallo 1D:
$102.38
$112.64
Intervallo di 1 settimana:
$100.00
$112.64
Portata 52W:
$7.575
$112.64
Celcuity Inc Stock (CELC) Company Profile
Nome
Celcuity Inc
Settore
Industria
Telefono
763-392-0767
Indirizzo
16305 36TH AVENUE N, MINNEAPOLIS, MN
Confronta CELC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
105.25 | 4.66B | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-18 | Iniziato | Wolfe Research | Outperform |
| 2025-11-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-09-22 | Iniziato | Guggenheim | Buy |
| 2025-07-01 | Ripresa | Stifel | Buy |
| 2024-07-22 | Iniziato | Leerink Partners | Outperform |
| 2024-02-22 | Iniziato | Stifel | Buy |
| 2023-12-08 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-08 | Iniziato | Canaccord Genuity | Buy |
| 2021-09-07 | Iniziato | Jefferies | Buy |
| 2021-07-29 | Iniziato | Cowen | Outperform |
| 2021-07-27 | Iniziato | Needham | Buy |
| 2021-01-28 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-11 | Ripresa | Craig Hallum | Buy |
| 2018-11-20 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Celcuity Inc Borsa (CELC) Ultime notizie
Celcuity (NASDAQ:CELC) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
Celcuity (NASDAQ:CELC) Hits New 1-Year HighShould You Buy? - MarketBeat
Eventide Asset Management LLC Buys 123,774 Shares of Celcuity, Inc. $CELC - MarketBeat
Wells Fargo Initiates Coverage of Celcuity (CELC) with Overweight Recommendation - Nasdaq
Is CELC Stock Overpriced? - timothysykes.com
RH Posts Strong Q3 Sales, Joins Canopy Growth, Tilray Brands, Frequency Electronics And Other Big Stocks Moving Higher On Friday - Benzinga
Celcuity stock hits all-time high at 109.15 USD By Investing.com - Investing.com Canada
Celcuity stock hits all-time high at 109.15 USD - Investing.com
Wells Fargo Initiates Celcuity With Overweight Rating, $126 Price Target - marketscreener.com
Celcuity Inc. (CELC)’s FDA NDA for Gedatolisib Accepted Under RTOR, Accelerating Review - MSN
Tracking the Top-Performing Russell 2000 Stocks Against the Zacks Rank - Finviz
Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium - The Manila Times
Director Cashes Out: Celcuity Stock Sale Revealed! - TipRanks
Richard Buller Sells 3,000 Shares of Celcuity (NASDAQ:CELC) Stock - MarketBeat
New Highs: How interest rate cuts could boost Celcuity Inc stockWeekly Trade Summary & Safe Entry Zone Identification - BỘ NỘI VỤ
Dir Furcht Acquires 250 Of Celcuity Inc [CELC] - TradingView
Earnings Update: Why Celcuity Inc. stock is trending among retail tradersJuly 2025 Breakouts & Safe Entry Trade Signal Reports - BỘ NỘI VỤ
(CELC) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Celcuity stock rallies on Phase III breast cancer trial progress - MSN
17,848 Shares in Celcuity, Inc. $CELC Purchased by M Holdings Securities Inc. - MarketBeat
Celcuity, Inc. (NASDAQ:CELC) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Celcuity (CELC) Price Target Increased by 11.17% to 108.57 - Nasdaq
Dir Buller Files To Sell 3,000 Of Celcuity Inc [CELC] - TradingView
Celcuity (NASDAQ:CELC) Sets New 1-Year HighShould You Buy? - MarketBeat
Saturn V Capital Management LP Boosts Stock Position in Celcuity, Inc. $CELC - MarketBeat
Geode Capital Management LLC Sells 42,691 Shares of Celcuity, Inc. $CELC - MarketBeat
Could Celcuity Drain The Lifeline Of Tumor Growth With Gedatolisib's Comprehensive Approach? - RTTNews
Aug Reactions: Why Celcuity Inc stock is rated strong buyPortfolio Value Summary & Free Accurate Trade Setup Notifications - BỘ NỘI VỤ
Celcuity stock hits all-time high at 103.23 USD By Investing.com - Investing.com Canada
Celcuity Stock Near All-Time Highs — And This Major Biotech Investor Is Still Jumping In - AOL.com
Is Celcuity Inc. stock a defensive play in 2025Weekly Trend Summary & Stock Portfolio Risk Management - Newser
3 Stocks You’ll Wish You Bought Before 2026 - Investing.com
Celcuity Director Cashes In on Stock Sale! - TipRanks
Celcuity (NASDAQ:CELC) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - MarketBeat
Aug Swings: Does Celcuity Inc stock trade at a discount to peersWeekly Stock Summary & Long-Term Investment Growth Plans - BỘ NỘI VỤ
Jefferies Maintains Celcuity (CELC) Buy Recommendation - MSN
Celcuity submits gedatolisib new drug application to the FDA - MSN
Is Celcuity Inc. stock a bargain at current levelsEarnings Growth Report & Real-Time Chart Breakout Alerts - Newser
Jefferies raises Celcuity stock price target to $134 on positive trial outlook By Investing.com - Investing.com South Africa
Jefferies raises Celcuity stock price target to $134 on positive trial outlook - Investing.com
Dir Buller Files To Sell 1,100 Of Celcuity Inc [CELC] - TradingView
Is Celcuity Inc a good long term investmentChart Pattern Recognition & Small Budget Capital Growth - earlytimes.in
How to Value Roto Pumps Limited Stock Using DCF AnalysisTechnical Resistance Breaks & Rapid Capital Growth - earlytimes.in
Virtus Investment Advisers LLC Has $100,000 Stock Position in Celcuity, Inc. $CELC - MarketBeat
Celcuity outlines $2.5B–$3B peak revenue potential for gedatolisib amid accelerated launch preparations - MSN
How FDA Real-Time Review for Gedatolisib Has Changed Celcuity’s (CELC) Investment Story - simplywall.st
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results - AOL.com
Celcuity (CELC): Assessing Valuation Following Recent Share Price Surge - Yahoo Finance
Celcuity: From Speculative Bet To Pre-Commercial Powerhouse (NASDAQ:CELC) - Seeking Alpha
Aug Intraday: Does Celcuity Inc. stock trade at a discount to peersPortfolio Gains Summary & Free Low Drawdown Momentum Trade Ideas - moha.gov.vn
(CELC) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Celcuity Inc Azioni (CELC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):